Nephroureteral Stent Market

Nephroureteral Stent Market Size and Share Forecast Outlook 2025 to 2035

The Nephroureteral Stent Market is estimated to be valued at USD 3.1 billion in 2025 and is projected to reach USD 5.5 billion by 2035, registering a compound annual growth rate (CAGR) of 5.9% over the forecast period.

Quick Stats for Nephroureteral Stent Market

• Nephroureteral Stent Market Value (2025): USD 3.1 billion
• Nephroureteral Stent Market Forecast Value (2035): USD 5.5 billion
• Nephroureteral Stent Market Forecast CAGR: 5.9%
• Leading Segment in Nephroureteral Stent Market in 2025: Retrograde Stents (40.2%)
• Key Growth Regions in Nephroureteral Stent Market: North America, Asia-Pacific, Europe
• Top Key Players in Nephroureteral Stent Market: Boston Scientific, C. R. Bard, Cook Medical, Medline Industries, Pnn Medical, Allium Medical, B. Braun, Dextronix

Nephroureteral Stent Market Key Takeaways

Metric	Value
Nephroureteral Stent Market Estimated Value in (2025 E)	USD 3.1 billion
Nephroureteral Stent Market Forecast Value in (2035 F)	USD 5.5 billion
Forecast CAGR (2025 to 2035)	5.9%

Why is the Nephroureteral Stent Market Growing?

The Nephroureteral Stent market is demonstrating steady growth as the prevalence of urological disorders, kidney stones, and urinary tract obstructions continues to rise globally. Increasing adoption of minimally invasive procedures, coupled with advancements in stent design and biomaterial technologies, is fueling market expansion. Healthcare providers are focusing on improving patient outcomes and reducing recovery times, which has increased the use of nephroureteral stents in both acute and chronic conditions.

The growing aging population, which is more susceptible to kidney-related disorders, is further driving demand. Additionally, rising healthcare spending, improved diagnostic rates, and increased awareness of treatment options are contributing to market growth. The introduction of stents with enhanced biocompatibility, reduced encrustation, and improved durability has strengthened clinical acceptance.

Regulatory approvals of innovative designs and growing access to urology services in emerging economies are expected to support long-term market expansion As the need for efficient, reliable, and patient-friendly treatment options grows, the nephroureteral stent market is anticipated to maintain its growth trajectory, with technological innovation serving as a key driver.

Segmental Analysis

The nephroureteral stent market is segmented by product, application, and geographic regions. By product, nephroureteral stent market is divided into Retrograde Stents, Antegrade Stents, and Internal (Double-J) Stents. In terms of application, nephroureteral stent market is classified into Lithotripsy, Ureteroscopy, Ureteroenoscopy, and Percutaneous Nephrolithotomy. Regionally, the nephroureteral stent industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Retrograde Stents Product Segment

The retrograde stents product segment is projected to account for 40.2% of the market revenue in 2025, making it the leading product category. Growth in this segment is being driven by its effectiveness in treating urinary tract obstructions and facilitating smooth urine flow from the kidneys to the bladder. Retrograde stents are favored by urologists due to their ease of insertion, high success rates in minimally invasive procedures, and reduced patient discomfort.

Advances in material design, such as the use of polyurethane and silicone coatings, are improving flexibility, biocompatibility, and resistance to encrustation, thereby enhancing patient outcomes. Hospitals and specialty clinics are increasingly relying on retrograde stents because they allow for safe placement using cystoscopic techniques, ensuring shorter procedure times and faster recovery.

The cost-effectiveness of retrograde stents compared to alternative interventions has further bolstered their adoption As the prevalence of kidney stone cases and related urological conditions continues to rise, demand for retrograde stents is expected to strengthen, supporting their leading role in the nephroureteral stent market.

Insights into the Lithotripsy Application Segment

The lithotripsy application segment is anticipated to hold 45.7% of the market revenue share in 2025, positioning it as the leading application area. Its growth is being driven by the rising incidence of kidney stones and the increasing preference for non-invasive or minimally invasive stone removal procedures. Nephroureteral stents play a vital role in lithotripsy by ensuring proper drainage and preventing complications such as ureteral obstruction or infection following stone fragmentation.

The ability of stents to facilitate smooth passage of residual fragments and reduce postoperative discomfort has reinforced their importance in lithotripsy procedures. Growing adoption of advanced lithotripsy techniques, including extracorporeal shock wave lithotripsy and laser-based methods, is further increasing reliance on stent placement for procedural success.

Hospitals and urology centers are increasingly integrating stent placement as a standard step in lithotripsy protocols to minimize risks and improve patient outcomes With kidney stone prevalence rising due to lifestyle changes and dietary factors, the lithotripsy application segment is expected to remain dominant, supported by innovation in stent design and increased treatment adoption worldwide.

Market Overview

Nephroureteral Stent Market Overview

A nephroureteral stent, sometimes as well called ureteric stent, it’s a thin tube inserted into the ureter to prevent or treat obstruction of the urine flow due to conditions such as kidney stone, tumors, infections, etc.

A nephroureteral stent is specially designed a soft tube 10-12 inches in length that is placed in the ureter for draining urine from the kidney to the urinary bladder. The length of the stents used in adult patients varies from 24 to 30 cm additionally, stents come in differing diameters or gauges, to fit different size ureters.

The stent is usually inserted with the aid of a cystoscope.

Normally a person can have nephroureteral stents for not more than 3 to 6 months. If left for longer duration, there can be a chance of secondary complications like stone formation, urethral infection, etc. which makes removal of stents difficult. Several market players are researching to overcome the issue of biofilm formation and mineralogical encrustation.

Analysis of Nephroureteral Stent Market By Key Countries

Country	CAGR
China	8.0%
India	7.4%
Germany	6.8%
France	6.2%
UK	5.6%
USA	5.0%
Brazil	4.4%

Country-wise Analysis

The Nephroureteral Stent Market is expected to register a CAGR of 5.9% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 8.0%, followed by India at 7.4%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 4.4%, yet still underscores a broadly positive trajectory for the global Nephroureteral Stent Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 6.8%. The USA Nephroureteral Stent Market is estimated to be valued at USD 1.1 billion in 2025 and is anticipated to reach a valuation of USD 1.9 billion by 2035. Sales are projected to rise at a CAGR of 5.0% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 141.9 million and USD 104.0 million respectively in 2025.

Key Players in the Nephroureteral Stent Market

• Boston Scientific
• C. R. Bard
• Cook Medical
• Medline Industries
• Pnn Medical
• Allium Medical
• B. Braun
• Dextronix

Scope of the Report

Item	Value
Quantitative Units	USD 3.1 Billion
Product	Retrograde Stents, Antegrade Stents, and Internal (Double-J) Stents
Application	Lithotripsy, Ureteroscopy, Ureteroenoscopy, and Percutaneous Nephrolithotomy
Regions Covered	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Covered	United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa
Key Companies Profiled	Boston Scientific, C. R. Bard, Cook Medical, Medline Industries, Pnn Medical, Allium Medical, B. Braun, and Dextronix

Nephroureteral Stent Market by Segments

Product:

• Retrograde Stents
• Antegrade Stents
• Internal (Double-J) Stents

Application:

• Lithotripsy
• Ureteroscopy
• Ureteroenoscopy
• Percutaneous Nephrolithotomy

Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa